# Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity

> **NCT04689672** · — · UNKNOWN · sponsor: **IRCCS San Raffaele** · enrollment: 600 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Lung ultrasound

## Key facts

- **NCT ID:** NCT04689672
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-16
- **Primary completion:** 2021-05-10
- **Final completion:** 2021-05-10
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04689672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04689672, "Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04689672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*